ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,232Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 783

$787K Total Retail Price of All Prescriptions

Rank: 101 out of 783

606 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,310 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 749 434 S3 1 2
LEVOTHYROXINE SODIUM 471 318 2 1
METFORMIN HCL 371 261 3 8
AMLODIPINE BESYLATE 336 257 4 5
LISINOPRIL 327 208 5 4
PRAVASTATIN SODIUM 308 203 6 14
SIMVASTATIN 297 245 7 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 274 204 8 33
GLIMEPIRIDE 272 189 9 34
FUROSEMIDE 255 194 10 7
ZOLPIDEM TARTRATE 214 112 11 23
CITALOPRAM HBR 200 146 12 19
OMEPRAZOLE 194 89 13 6
MELOXICAM 185 143 14 37
ATENOLOL 172 125 15 17
TRAMADOL HCL 145 69 16 20
CARVEDILOL 134 110 17 21
ATORVASTATIN CALCIUM 134 118 17 11
METOPROLOL SUCCINATE 119 97 19 13
LOSARTAN-HYDROCHLOROTHIAZIDE 119 107 19 53
METOPROLOL TARTRATE 118 96 21 9
CRESTOR 117 65 22 27
VENLAFAXINE HCL ER 116 64 23 100
SERTRALINE HCL 115 91 24 22
POTASSIUM CHLORIDE 108 74 25 16
NEXIUM 106 92 26 28
AZITHROMYCIN 100 62 27 41
DIOVAN HCT 95 89 28 94
TAMSULOSIN HCL 94 65 29 26
KLOR-CON M20 93 74 30 48
ALLOPURINOL 89 66 31 31
GABAPENTIN 88 80 32 15
PROAIR HFA 85 36 33 56
HYDROCHLOROTHIAZIDE 84 75 34 12
CLOPIDOGREL 83 55 35 29
SPIRIVA 79 64 36 59
PREDNISONE 78 51 37 36
FENOFIBRATE 77 34 38 66
AMLODIPINE BESYLATE-BENAZEPRIL 77 39 38 83
AMOXICILLIN 77 57 38 116
ADVAIR DISKUS 76 58 41 50
LANTUS SOLOSTAR 76 58 41 91
PANTOPRAZOLE SODIUM 74 53 43 30
CIPROFLOXACIN HCL 74 55 43 62
LOSARTAN POTASSIUM 72 57 45 18
ISOSORBIDE MONONITRATE ER 69 57 46 40
PAROXETINE HCL 69 32 46 69
LANTUS 68 58 48 38
TRILIPIX 67 46 49 192
FAMOTIDINE 67 30 49 55
RANITIDINE HCL 64 34 51 44
METHYLPREDNISOLONE 64 49 51 138
AMITRIPTYLINE HCL 59 29 R 53 77
ALENDRONATE SODIUM 59 55 53 25
DIGOXIN 59 45 53 61
PLAVIX 58 35 56 51
CYCLOBENZAPRINE HCL 53 25 R 57 63
CLOTRIMAZOLE-BETAMETHASONE 53 36 57 189
CYMBALTA 52 35 59 35
WARFARIN SODIUM 51 27 60 10
COMBIVENT 50 12 61 120
SPIRONOLACTONE 50 22 61 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.